Drug news
Numeta (Baxter) launched in EU for I.V. Nutrition
Baxter International Inc.,announced today the European launch of Numeta (emulsion for infusion) as the first and only triple-chamber system with formulations specifically designed to meet the range of intravenous (IV) nutritional requirements of neonatal and pediatric patients (preterm newborns through age 18). This premix therapy addresses an important unmet medical need to support neonatal and pediatric patients' changing daily nutritional needs with ready-to-use IV nutrition.